Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2012; 18(46): 6782-6789
Published online Dec 14, 2012. doi: 10.3748/wjg.v18.i46.6782
Published online Dec 14, 2012. doi: 10.3748/wjg.v18.i46.6782
Table 2 The use of faecal calprotectin to predict relapse
Author | Patient population | Cut-off calprotectin level | Sensitivity for relapse (%) | Specificity for relapse (%) | Increased risk of relapse |
Costa et al[21] | UC | 150 μ/L | 89 | 82 | 14 fold |
CD | 87 | 43 | 2 fold | ||
D'Incà et al[29] | UC | 130 mg/kg | 70 | 70 | 2.4 fold |
CD | 65 | 62 | 1.7 fold | ||
García-Sánchez et al[30] | CD + UC | 120 μ/g | 80 | 60 | |
Ileal CD | 223 μ/g | 83 | 50 | ||
Tibble et al[49] | CD + UC | 50 mg/L (250 μ/g) | 90 | 83 | |
Laharie et al[50] | CD post IFX | 130 μ/g | 61 | 48 | |
250 μ/g | 43 | 57 | |||
Kallel et al[70] | Colonic CD | 340 μ/g | 80 | 90.7 | 18.8 fold |
Gisbert et al[71] | CD + UC | 150 μ/g | 69 | 69 |
- Citation: Smith LA, Gaya DR. Utility of faecal calprotectin analysis in adult inflammatory bowel disease. World J Gastroenterol 2012; 18(46): 6782-6789
- URL: https://www.wjgnet.com/1007-9327/full/v18/i46/6782.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i46.6782